GI
GMAB icon

GAMMA Investing’s Genmab GMAB Stock Holding History

GAMMA Investing’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
3,978
+561
+16% +$14.9K ﹤0.01% 1748
2026
Q1 		$91.7K Sell
3,417
-1,338
-28% -$40.1K ﹤0.01% 1753
2025
Q4 		$146K Buy
4,755
+1,773
+59% +$55.3K 0.01% 1270
2025
Q3 		$91.5K Buy
2,982
+1,063
+55% +$25.9K 0.01% 1563
2025
Q2 		$39.6K Buy
1,919
+209
+12% +$4.29K ﹤0.01% 2066
2025
Q1 		$33.5K Sell
1,710
-429
-20% -$9K ﹤0.01% 2073
2024
Q4 		$44.6K Buy
2,139
+1,051
+97% +$23.1K ﹤0.01% 1745
2024
Q3 		$26.5K Buy
1,088
+335
+44% +$8.96K ﹤0.01% 1932
2024
Q2 		$18.9K Sell
753
-382
-34% -$10.8K ﹤0.01% 1894
2024
Q1 		$33.9K Buy
1,135
+749
+194% +$22K 0.01% 1288
2023
Q4 		$10.7K Buy
+386
New +$12.1K ﹤0.01% 1868

Other funds holding GMAB

PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GAMMA Investing's GMAB Position: Q2 2026 in Review

GAMMA Investing increased its Genmab (GMAB) stake by 16% in Q2 2026, buying an estimated $14.9K and bringing the position to 3,978 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1748.

GAMMA Investing first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $146K in Q4 2025. 43 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • GAMMA Investing held 3,978 shares of Genmab worth $109K as of Q2 2026.
  • GAMMA Investing bought 561 Genmab shares in Q2 2026, an estimated $14.9K.
  • Genmab made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1748 holding.
  • GAMMA Investing first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Genmab position peaked at $146K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.